Skip to main content

Find Clinical Trials

Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,918 public trials 501 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Hepatitis B and HIV Co-Infection in Patients in Uganda

NCT00782158

Conditions: Blood-Borne Infections, Coinfection, Communicable Diseases, +23 more
Locations: Infectious Diseases Institute Kampala, Uganda

International Ctr for Excellence in Research and Rakai Health Sciences Program Rakai, Uganda

View Trial Details

Completed

Immune Response to Shingles Vaccination

NCT02624375

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: University of Washington Virology Research Clinic Seattle, Washington, United States

View Trial Details

Completed

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

NCT04168333

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: The First Hospital of Jilin University Changchun, China

View Trial Details

Completed

Proper Timing of Control of Hypertension and Outcome in Acute Spontaneous Intracerebral Hemorrhage.

NCT04167644

Conditions: Adenoviridae Infections, Animal Diseases, Brain Diseases, +22 more
Locations: Mansoura University Hospital Al Mansurah, Egypt

View Trial Details

Completed

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

NCT04083716

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Celerion Tempe, Arizona, United States

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

NCT00753649

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Edmonton, Alberta, Canada

GSK Investigational Site Vancouver, British Columbia, Canada

GSK Investigational Site Truro, Nova Scotia, Canada

View Trial Details

Completed

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Fayetteville, Arkansas, United States

GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Daly City, California, United States

View all 43 locations

View Trial Details

Completed

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

NCT04177485

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +41 more
Locations: Not specified

View Trial Details

Completed

HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs

NCT04133610

Conditions: Cervical Cancer, Cervical Dysplasia, Communicable Diseases, +26 more
Locations: GYN-PREN, Ltd. Frýdek-Místek, Czechia

GYNPRENATAL, Ltd. Havířov, Czechia

MEDIOL, Ltd. Olomouc, Czechia

View Trial Details

Completed

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

NCT02570126

Conditions: Chicken-pox Illness (Varicella Virus Disease), Chickenpox, DNA Virus Infections, +4 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 23 locations

View Trial Details